Persons Reported to be living with HIV infection and with AIDS reported
Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 4,611 4,618 73 23 4,684 4,641 9,229 96 9,325
2001

5,106

4,661

 74 23 5,180 4,884 9,967 97 10,064
2002 6,006 5,371 124 25 6,130 5,395 11,377 149 11,525
                   

 

HIV Infection Cases  from areas with confidential HIV infection reporting
Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 644 5,325 107 5,432
2001 674 5,858 118 5,976
2002 584 6,006 124 6,130
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States
Year Males Females
  HIV AIDS HIV AIDS
2000 463 564 177 200
2001 490 411 174 136
         

 

New Pediatric AIDS cases reported

Year
2000 6
2001 0

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through June 2001

 

 1999

2000

2001

Cumulative Totals
City No No. No. Adults / Adolescents Children under 13 Years old Total

Ann Harbor

 27 35 14 412 9 421
Detroit 417 550 389 8,123 73 8,196
Grand Rapids 40 37 42 805 4 809

 

Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 12,645
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 12,535
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 110

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002
  MI USA
Men 10,082 680,909
Women 2,030 146,298
Total 12,112 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 789
New Adult/Adolescent AIDS Cases, Reported in 2001 547
New AIDS Cases in Children <13, Reported through December 2001 1

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001
  MI USA
Men 411 31,901
Women 136 11,082
Total 547 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 5,395
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 5,371
Estimated Number of Children Living with AIDS at the End of 2002 25
HIV Infection Cases Reported in 2002 584

 

 

Total Deaths Reported through 2000, due to AIDS = 7,128
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Anonymous and Confidential testing
Definitions: Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?  Providers required to test for HIV unless mother refuses. All health care providers are required by law to conduct an HIV test unless the woman objects.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration? NO
Definitions: 1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 
Sterile Syringe Exchange Programs?  Yes
Notes: U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  Yes, must cover abstinence.
 
Minors' Right to Consent to HIV/STD Services?  Yes. State explicitly classifies HIV/AIDS as an STD or infectious disease, for which minors may consent to testing and treatment. Physician may notify parents.
 

 

Total Ryan White Funding, FY2000   $23,484,876 FY2002  $27,213,618

 

CDC HIV Prevention Funding for States
 FY2001  $6,694,576

 FY2003   $6,743,243

 

Total Federal and State Funding for ADAP, FY2000  $8,274,199

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  MI
#		 US
#
   664 80,035

 
ADAP Clients Served by Sex, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  Male 564 85 62,034 78
  Female 100 15 16,702 21
  Total 664 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  White 392 59 29,426 37
  Black 219 33 26,245 33
  Hispanic 40 6 19,883 25
  Asian/Pacific Islander 7 1 795 1
  American Indian/Alaskan Native 7 1 795 1
  Other 0 0 795 1
  Total 664 100 79,531 100

 
ADAP Clients Served by Age, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  <13 years old 7 1 795 1
  13-19 years old 7 1 0 1 0 1
  20-44 years old 412 62 50,105 63
  >44 years old 239 36 27,836 35
  Total 664 100 79,531 100

 
ADAP Clients Served by Income, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  <100% FPL 378 57 38,175 48
  101-200% FPL 226 34 26,245 33
  201-300% FPL 40 6 8,748 11
  301-400% FPL 13 2 3,181 4
  >400% FPL 7 1 1,591 2
  Total 664 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  Medicaid 199 30 0 10
  Medicare 186 28 0 6
  Private 146 22 0 13

  
National ADAP Budget, Total Federal and State Sources, FY 2002  
  MI
$		 US
$
   9,327,488 878,610,754

 
National ADAP Budget by Source, FY 2002  
  MI
$		 MI
%		 US
$		 US
%
  ADAP Earmark 9,327,488 100 619,830,000 71
  Title II Base 0 0 28,886,192 3
  State 0 0 160,385,979 18
  Title I 0 0 19,736,619 2
  Other Federal 0 0 30,941,439 4
  ADAP Supplemental Grants 0 0 19,170,000 2
  Total 9,327,488 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  MI
$		 US
$
   640,295 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  MI
$		 MI
%		 US
$		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 303,017 47 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 72,595 11 7,940,575 12
  Protease Inhibitors 157,139 25 16,433,502 25
  Opportunistic Infections/Other 107,544 17 9,015,329 14
  Total 640,295 100 64,875,793 100

 

Total ADAP Prescriptions Filled, June 2002  
  MI
#		 US
#
   2,681 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
  MI
#		 MI
%		 US
#		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 844 31 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 256 10 23,933 10
  Protease Inhibitors 383 14 33,813 15
  Opportunistic Infections/Other 1,198 45 87,746 38
  Total 2,681 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  MI
$		 US
$
   300,000 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  MI
#		 US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 13 NA
  Other Medications Covered 129 NA
  Total 160 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  MI
 		 US
 
  Has ADAP Emergency Cost Containment Measures in Place No 16 Yes
  Notes